Chinese General Practice ›› 2021, Vol. 24 ›› Issue (36): 4628-4632.DOI: 10.12114/j.issn.1007-9572.2021.02.064
Special Issue: 神经系统疾病最新文章合集; 老年问题最新文章合集
• Monographic Research • Previous Articles Next Articles
Published:
2021-12-20
Online:
2021-12-20
基金资助:
ZHANG Donglin,LI Chengliang,LI Dan,WANG Minjuan. Study on the Level of Parathyroid Hormone and Severity and Prognosis of Cerebral Ischemic Stroke Severity in Middle-aged and Elderly People [J]. Chinese General Practice, 2021, 24(36): 4628-4632.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2021.02.064
项目 | 病例组(n=79) | 对照组(n=65) | t(χ2)值 | P值 |
---|---|---|---|---|
年龄(岁) | 67.73±11.33 | 66.08±5.611 | 1.076 | 0.284 |
性别(男/女) | 52/27 | 31/34 | 4.801a | 0.042 |
吸烟〔n(%)〕 | 26(32.9) | 16(24.6) | 1.188a | 0.357 |
饮酒〔n(%)〕 | 7(8.9) | 6(9.2) | 0.006a | 0.582 |
高血压病〔n(%)〕 | 42(53.2) | 22(33.8) | 5.390a | 0.028 |
糖尿病〔n(%)〕 | 13(16.5) | 17(26.2) | 2.034a | 0.216 |
冠心病〔n(%)〕 | 25(31.6) | 19(29.2) | 0.098a | 0.856 |
收缩压(mm Hg) | 143±22 | 130±15 | 4.374 | <0.001 |
舒张压(mm Hg) | 86±13 | 76±8 | 6.201 | <0.001 |
WBC(×109/L) | 6.7±2.4 | 5.9±1.5 | 2.508 | 0.010 |
TC(mmol/L) | 4.21±0.96 | 4.00±0.91 | 1.375 | 0.171 |
TG(mmol/L) | 1.53±1.08 | 1.29±0.41 | 1.815 | 0.072 |
HDL-C(mmol/L) | 1.14±0.27 | 1.14±0.22 | 0.036 | 0.971 |
LDL-C(mmol/L) | 2.53±0.87 | 2.28±0.68 | 1.943 | 0.226 |
空腹血糖(mmol/L) | 6.2±1.9 | 6.5±1.7 | -1.206 | 0.230 |
血尿酸(μmol/L) | 302±96 | 312±92 | -0.594 | 0.552 |
血肌酐(μmol/L) | 71.3±22.6 | 66.6±18.2 | 1.359 | 0.176 |
BMI(kg/m2) | 24.2±3.6 | 23.4±3.1 | 1.245 | 0.217 |
PTH(ng/L) | 12.0±3.7 | 10.4±4.2 | 2.380 | 0.019 |
VD(pmol/L) | 122±29 | 130±21 | -2.005 | 0.047 |
IL-6(ng/L) | 7.1±1.5 | 6.4±0.9 | 3.136 | 0.002 |
Table 1 Comparison of the general data between the two groups
项目 | 病例组(n=79) | 对照组(n=65) | t(χ2)值 | P值 |
---|---|---|---|---|
年龄(岁) | 67.73±11.33 | 66.08±5.611 | 1.076 | 0.284 |
性别(男/女) | 52/27 | 31/34 | 4.801a | 0.042 |
吸烟〔n(%)〕 | 26(32.9) | 16(24.6) | 1.188a | 0.357 |
饮酒〔n(%)〕 | 7(8.9) | 6(9.2) | 0.006a | 0.582 |
高血压病〔n(%)〕 | 42(53.2) | 22(33.8) | 5.390a | 0.028 |
糖尿病〔n(%)〕 | 13(16.5) | 17(26.2) | 2.034a | 0.216 |
冠心病〔n(%)〕 | 25(31.6) | 19(29.2) | 0.098a | 0.856 |
收缩压(mm Hg) | 143±22 | 130±15 | 4.374 | <0.001 |
舒张压(mm Hg) | 86±13 | 76±8 | 6.201 | <0.001 |
WBC(×109/L) | 6.7±2.4 | 5.9±1.5 | 2.508 | 0.010 |
TC(mmol/L) | 4.21±0.96 | 4.00±0.91 | 1.375 | 0.171 |
TG(mmol/L) | 1.53±1.08 | 1.29±0.41 | 1.815 | 0.072 |
HDL-C(mmol/L) | 1.14±0.27 | 1.14±0.22 | 0.036 | 0.971 |
LDL-C(mmol/L) | 2.53±0.87 | 2.28±0.68 | 1.943 | 0.226 |
空腹血糖(mmol/L) | 6.2±1.9 | 6.5±1.7 | -1.206 | 0.230 |
血尿酸(μmol/L) | 302±96 | 312±92 | -0.594 | 0.552 |
血肌酐(μmol/L) | 71.3±22.6 | 66.6±18.2 | 1.359 | 0.176 |
BMI(kg/m2) | 24.2±3.6 | 23.4±3.1 | 1.245 | 0.217 |
PTH(ng/L) | 12.0±3.7 | 10.4±4.2 | 2.380 | 0.019 |
VD(pmol/L) | 122±29 | 130±21 | -2.005 | 0.047 |
IL-6(ng/L) | 7.1±1.5 | 6.4±0.9 | 3.136 | 0.002 |
项目 | 偏回归系数 | 标准误 | OR值 | 95%CI | Wald χ2值 | P值 |
---|---|---|---|---|---|---|
舒张压 | -0.101 | 0.021 | 0.904 | (0.866,0.942) | 22.405 | <0.001 |
PTH | -0.130 | 0.052 | 0.878 | (0.793,0.972) | 6.295 | 0.012 |
IL-6 | -0.558 | 0.202 | 0.566 | (0.381,0.842) | 7.893 | 0.005 |
Table 2 Binary Logistic regression analysis of influencing factors of ischemic stroke in middle-aged and elderly people
项目 | 偏回归系数 | 标准误 | OR值 | 95%CI | Wald χ2值 | P值 |
---|---|---|---|---|---|---|
舒张压 | -0.101 | 0.021 | 0.904 | (0.866,0.942) | 22.405 | <0.001 |
PTH | -0.130 | 0.052 | 0.878 | (0.793,0.972) | 6.295 | 0.012 |
IL-6 | -0.558 | 0.202 | 0.566 | (0.381,0.842) | 7.893 | 0.005 |
分级 | 例数 | PTH | F值 | P值 | |
---|---|---|---|---|---|
脑梗死面积 | 11.163 | <0.001 | |||
小 | 35 | 9.1±1.6 | |||
中 | 33 | 12.0±2.0 | |||
大 | 21 | 15.6±2.0 | |||
神经功能缺损情况 | 0.355 | 0.702 | |||
轻 | 36 | 12.1±3.7 | |||
中 | 34 | 11.7±3.6 | |||
重 | 9 | 12.9±2.0 | |||
神经功能恢复状况 | 6.530 | 0.002 | |||
好 | 35 | 10.4±3.0 | |||
中 | 27 | 13.6±3.8 | |||
差 | 17 | 12.7±1.0 |
Table 3 Comparison of PTH in patients with acute ischemic stroke with different cerebral infarction area,neurological deficit and neurological recovery
分级 | 例数 | PTH | F值 | P值 | |
---|---|---|---|---|---|
脑梗死面积 | 11.163 | <0.001 | |||
小 | 35 | 9.1±1.6 | |||
中 | 33 | 12.0±2.0 | |||
大 | 21 | 15.6±2.0 | |||
神经功能缺损情况 | 0.355 | 0.702 | |||
轻 | 36 | 12.1±3.7 | |||
中 | 34 | 11.7±3.6 | |||
重 | 9 | 12.9±2.0 | |||
神经功能恢复状况 | 6.530 | 0.002 | |||
好 | 35 | 10.4±3.0 | |||
中 | 27 | 13.6±3.8 | |||
差 | 17 | 12.7±1.0 |
[1] | O'NEILL D. Global burden of stroke:an underestimate[J]. Lancet,2014,383(9924):1205. DOI:10.1016/S0140-6736(14)60595-X. |
[2] | DELLA-MORTE D, GUADAGNI F, PALMIROTTA R,et al. Genetics of ischemic stroke,stroke-related risk factors,stroke precursors and treatments[J]. Pharmacogenomics,2012,13(5):595-613. DOI:10.2217/pgs.12.14. |
[3] | SCHILLACI G, PUCCI G, PIRRO M,et al. Large-artery stiffness:a reversible marker of cardiovascular risk in primary hyperparathyroidism[J]. Atherosclerosis,2011,218(1):96-101. DOI:10.1016/j.atherosclerosis.2011.05.010. |
[4] | GOETTSCH C, IWATA H, AIKAWA E. Parathyroid hormone:critical bridge between bone metabolism and cardiovascular disease[J]. Arterioscler Thromb Vasc Biol,2014,34(7):1333-1335. DOI:10.1161/ATVBAHA.114.303637. |
[5] | WANNAMETHEE S G, WELSH P, PAPACOSTA O,et al. Elevated parathyroid hormone,but not vitamin D deficiency,is associated with increased risk of heart failure in older men with and without cardiovascular disease[J]. Circ Heart Fail,2014,7(5):732-739. DOI:10.1161/CIRCHEARTFAILURE.114.001272. |
[6] | LISHMANOV A, DORAIRAJAN S, PAK Y,et al. Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease[J]. Int Urol Nephrol,2012,44(2):541-547. DOI:10.1007/s11255-010-9897-2. |
[7] | 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2014[J]. 中华神经科杂志,2015,48(4):246-257. DOI:10.3760/cma.j.issn.1006-7876.2015.04.002. |
[8] | BOSWORTH C, SACHS M C, DUPREZ D,et al. Parathyroid hormone and arterial dysfunction in the multi-ethnic study of atherosclerosis[J]. Clin Endocrinol (Oxf),2013,79(3):429-436. DOI:10.1111/cen.12163. |
[9] | STRUCK J, MORGENTHALER N G, BERGMANN A. Copeptin,a stable peptide derived from the vasopressin precursor,is elevated in serum of Sepsis patients[J]. Peptides,2005,26(12):2500-2504. DOI:10.1016/j.peptides.2005.04.019. |
[10] | ÇELIK G, DOGAN A, DENER S,et al. Parathyroid hormone levels in the prediction of ischemic stroke risk[J]. Dis Markers,2017,2017:4343171. DOI:10.1155/2017/4343171. |
[11] | SUN Q, PAN A, HU F B,et al. 25-Hydroxyvitamin D levels and the risk of stroke:a prospective study and meta-analysis[J]. Stroke,2012,43(6):1470-1477. DOI:10.1161/STROKEAHA.111.636910. |
[12] | ZHANG Y F, JIANG L, YANG P,et al. Comparison of lymphocyte count,neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in predicting the severity and the clinical outcomes of acute cerebral infarction patients[J]. Clin Lab,2019,65(7):102-106. DOI:10.7754/Clin.Lab.2019.190102. |
[13] | VILA N, CASTILLO J, DÁVALOS A,et al. Proinflammatory cytokines and early neurological worsening in ischemic stroke[J]. Stroke,2000,31(10):2325-2329. DOI:10.1161/01.str.31.10.2325. |
[14] | ACALOVSCHI D, WIEST T, HARTMANN M,et al. Multiple levels of regulation of the interleukin-6 system in stroke[J]. Stroke,2003,34(8):1864-1869. DOI:10.1161/01.STR.0000079815.38626.44. |
[15] | DAUBAIL B, JACQUIN A, GUILLAND J C,et al. Serum 25-hydroxyvitamin D predicts severity and prognosis in stroke patients[J]. Eur J Neurol,2013,20(1):57-61. DOI:10.1111/j.1468-1331.2012.03758.x. |
[16] | PARK K Y, CHUNG P W, KIM Y B,et al. Serum vitamin D status as a predictor of prognosis in patients with acute ischemic stroke[J]. Cerebrovasc Dis,2015,40(1/2):73-80. DOI:10.1159/000434691. |
[17] | 王楠,张双,刘永政,等. 曲美他嗪联合运动康复对慢性心力衰竭患者心肾功能及甲状旁腺素的影响[J]. 实用心脑肺血管病杂志,2018,26(3):104-108. DOI:10.3969/j.issn.1008-5971.2018.03.030. |
[18] | HELDNER M R, ZUBLER C, MATTLE H P,et al. National Institutes of Health stroke scale score and vessel occlusion in 2152 patients with acute ischemic stroke[J]. Stroke,2013,44(4):1153-1157. DOI:10.1161/STROKEAHA.111.000604. |
[1] | QIN Fengyin, ZHANG Qishan, LAI Jinjia, HUANG Yimin, HAN Guoyin, SUN Xinglan, WANG Fen, TAN Yibing. Current Status and Influencing Factors of the Intention to Screen for High-risk Stroke among Community Residents in Guangdong [J]. Chinese General Practice, 2023, 26(34): 4283-4289. |
[2] | FENG Xiaoyu, LI Wanling, LYU Siman, NI Cuiping, WANG Haocheng, LIU Yu. International Research Status and Hot Spot Analysis of InterRAI HC Based on Bibliometrics [J]. Chinese General Practice, 2023, 26(34): 4351-4358. |
[3] | GU Hanxin, LIU Yang, LIU Yuanli. Falls Prevention Intervention for Community-dwelling Older Adults from the Perspective of Policy Tools: an International Comparative Study [J]. Chinese General Practice, 2023, 26(34): 4231-4238. |
[4] | HAO Aihua, ZENG Weilin, LI Guanhai, XIA Yinghua, CHEN Liang. Current Situation of the Construction of Family Doctor Team: an Investigation Based on the Perspective of General Practitioners [J]. Chinese General Practice, 2023, 26(34): 4261-4268. |
[5] | LI Dianjiang, PAN Enchun, SUN Zhongming, WEN Jinbo, WANG Miaomiao, WU Ming, SHEN Chong. The Current Status and Influencing Factors of Clinical Inertia in Type 2 Diabetes Patients in Community [J]. Chinese General Practice, 2023, 26(34): 4296-4301. |
[6] | WANG Yue, CHEN Qing, LIU Lurong. Detection Rate of Depression and Its Influencing Factors in Chinese Elderly: a Meta-analysis [J]. Chinese General Practice, 2023, 26(34): 4329-4335. |
[7] | YU Xinyan, ZHAO Jun, ZHAO Xiaoye, JIANG Qingru, CHEN Yatian, WANG Yan, ZHANG Haicheng. Application of Mobile Smart Healthcare in the Prevention and Control of Cardiovascular Diseases in Elderly Patients with Chronic Diseases in Primary Care [J]. Chinese General Practice, 2023, 26(33): 4167-4172. |
[8] | YIN Miaomiao, CUI Liling, LI Yaqing, WANG Liqun, ZHANG Yue, WU Jialing. Effect of Dual Task on Walking Ability in Posterior Circulation Ischemic Stroke Patients with Vestibular Symptoms [J]. Chinese General Practice, 2023, 26(33): 4207-4212. |
[9] | WANG Lina, GAO Pengfei, CAO Fan, GE Ying, YAN Wei, HE Daikun. Analysis of the Prevalence and Influencing Factors of Non-alcoholic Fatty Liver Disease in Different Gender Groups [J]. Chinese General Practice, 2023, 26(33): 4143-4151. |
[10] | XIN Gongkai, CONG Xin, YUAN Lei, CHENG Yuetong, NI Cuiping, ZHANG Weiwei, ZHANG Pingping, LIU Yu. Research Progress on Comprehensive Assessment Tools for the Elderly with Dementia [J]. Chinese General Practice, 2023, 26(33): 4103-4109. |
[11] | ZHOU Yuyu, GAO Chuan, CUI Puan, WANG Yaping, HE Zhong. Influencing Factors of Shared Decision Making between Doctors and Patients in Menopausal Hormone Therapy in Patients with Menopausal Syndrome [J]. Chinese General Practice, 2023, 26(33): 4181-4186. |
[12] | ZHANG Siyu, ZHOU Yuqiu, DU Xiaohui, WANG Zhengjun. Advances in Duration of Untreated Psychosis and Its Early Intervention [J]. Chinese General Practice, 2023, 26(33): 4110-4117. |
[13] | SU Kaiqi, LYU Zhuan, WU Mingli, LUO Meng, GAO Jing, NIE Chenchen, LIU Hao, FENG Xiaodong. Effect of Electroacupuncture on BDNF/TrkB/PI3K/Akt Pathway and Hippocampal Neuronal Protection in Rats with Learning and Memory Impairment after Ischemia Reperfusion [J]. Chinese General Practice, 2023, 26(33): 4187-4193. |
[14] | ZHANG Jin, DING Zhiguo, QI Shuo, LI Ying, LI Weiqiang, ZHANG Yuanyuan, ZHOU Tong. Relationship between Serum Thyroid Hormone Levels and Prognosis during Hospitalization in Heart Failure Patients [J]. Chinese General Practice, 2023, 26(33): 4125-4129. |
[15] | LI Qianqian, CHEN Xunrui, ZHANG Wenying, YUAN Haihua, ZHANG Yanjie, JIANG Bin, LIU Feng. Demand and Influencing Factors for Community Health Services during Chemotherapy of Patients with Advanced Cancer [J]. Chinese General Practice, 2023, 26(33): 4173-4180. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||